![Stefan Pflanz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stefan Pflanz
Directeur/Membre du Conseil chez
TigaTx, Inc.
Profil
Stefan Pflanz currently works at Boehringer Ingelheim (Venture Capital), as Executive Director from 2020, Bodyport, Inc., as Director, and TigaTx, Inc., as Director.
Postes actifs de Stefan Pflanz
| Sociétés | Poste | Début |
|---|---|---|
Boehringer Ingelheim (Venture Capital)
 Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors. | Private Equity Investor | 01/01/2020 |
Bodyport, Inc.
 Bodyport, Inc. Packaged SoftwareTechnology Services Publishes mobile applications which provides blood pressure, heart rate and other health information | Directeur/Membre du Conseil | - |
TigaTx, Inc.
 TigaTx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops engineered immunoglobulin to create isotype cancer antibody | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Boehringer Ingelheim (Venture Capital)
Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors. | Finance |
Bodyport, Inc.
Bodyport, Inc. Packaged SoftwareTechnology Services Publishes mobile applications which provides blood pressure, heart rate and other health information | Technology Services |
TigaTx, Inc.
TigaTx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops engineered immunoglobulin to create isotype cancer antibody | Health Technology |
